NSPR
- InspireMD, Inc.
()
Overview
Company Summary
InspireMD, Inc. is a medical device company specializing in the development and commercialization of proprietary innovations in the field of neurovascular and peripheral vascular diseases. The company's primary focus is on creating solutions to prevent complications associated with stenting procedures.
InspireMD has developed a unique, non-coronary, MicroNet technology platform that addresses the limitations of conventional stents. This technology incorporates a dense mesh net onto a stent, which acts as a barrier to prevent plaque prolapse and consequent complications such as embolization, restenosis (re-narrowing of arteries), and thrombus formation.
The MicroNet technology is primarily designed for the treatment of carotid artery stenosis, a condition in which the carotid arteries, responsible for supplying blood to the brain, become narrowed or blocked due to the buildup of plaque. By providing protection and support during the stenting procedure, this technology aims to improve patient outcomes and reduce the risk of post-procedure complications.
InspireMD, Inc. markets its products primarily under the brand name CGuard EPS (Embolic Prevention System) for carotid artery stenting. The CGuard system is compliant with various stent delivery systems and is designed to be used in combination with embolic protection devices, providing physicians with versatile options during the procedure.
In addition to carotid devices, InspireMD is also involved in the development of products for peripheral arterial disease, focusing on the treatment of lower limb ischemia. This condition occurs when blood flow is limited in the arteries of the lower limbs, leading to pain, ulcers, and other complications. The company's technology aims to address the challenges associated with peripheral stenting procedures, enhancing efficacy and reducing the risk of subsequent events.
By leveraging innovative technology and a commitment to improving patient outcomes, InspireMD, Inc. aims to provide physicians with advanced tools to overcome the limitations of conventional stents and improve the quality of care for patients with neurovascular and peripheral vascular diseases.